Bronşektazide Cerrahi Öncesi ve Sonrasında Uygulanan Pulmoner Rehabilitasyon Yöntemleri

Yıl 2019, Cilt: 2 Sayı: 1, 10 - 21, 22.05.2019

Neriman Temel Aksu , Abdullah Erdoğan

Öz

Bronşektazi
balgam üretimi ve tekrarlayan enfeksiyonla birlikte havayolunun kalıcı
genişlemesi durumudur. Bronşektazide cerrahi artık çok sık uygulanmamaktadır.
Fakat maksimal ilaç tedavisiyle kontrol altına alınamayan lokalize
bronşektazide cerrahi düşünülmektedir.

Cerrahi
öncesi aktif ve akut enfeksiyon antibiyotiklerle ciddi şekilde tedavi
edilmelidir. Komple bakterial eradikasyon imkansız olmasına rağmen, antibiyotik
tedavinin amaçları balgamın volümünü ve rengini azaltmaktır. Bu yüzden pürülan
ve bol balgamlı hastalarda göğüs fizyoterapisi ve antibiyotikler balgam volümü
minimum olana kadar ve rengi mukoid olana kadar devam edilmelidir. Bu minimum 2
haftayı almaktadır. Daha sonra bu hastalar cerrahi öncesi 2 gün yoğun göğüs
fizyoterapisi ve vibratör masajlı postüral drenaj programına alınmalıdırlar.
Buna postoperatif dönemde de devam edilmelidir. Proflaktik antibiyotiklere de
başlanmalı ve postoperatif 48 saate kadar verilmelidir.

Bronşektazi
cerrahisi sonrası tedavi akciğer rezeksiyonu geçiren hastalarla aynıdır. Erken
mobilizasyon, agresif pulmoner temizlik, göğüs fizyoterapisi ve beslenme
önemlidir. Bronşektazili hastaların egzersiz kapasitesi ve yaşam kalitesi
azalmaktadır.  Pulmoner rehabilitasyon bu
sorunları azaltabilmektedir. 

Bronşektazi
cerrahisi sonrası hastalara, standart akciğer rezeksiyonundan sonra uygulanan
tedavi yöntemleri uygulanmaktadır. Erken mobilizasyon, agresif pulmoner
temizlik, göğüs fizyoterapisi ve beslenme desteği önemli konulardandır.

Operasyon
öncesi ve sonrası uygulanan pulmoner rehabilitasyon programı; egzersiz ve
inspiratuar kas eğitimini, ventilasyonu arttıran teknikleri, hava yolu
temizleme tekniklerini ve hasta eğitimini içermektedir.

Anahtar Kelimeler

Bronşektazi, Cerrahi

Kaynakça

• Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Ionescu AA, Thomas J, Tunbridge J. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362-8.
• Barker AF, Bardana EJ. Bronchiectasis: update of an orphan disease. Am Rev Respir Dis 1988;137:969-78.
• Paganin F, Séneterre E, Chanez P, Daurés JP, Bruel JM, Michel FB, Bousquet J. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med 1996; 153:110-4.
• Poppelwell L, Chalmers JD. Defining severity in non-cystic fibrosis bronchiectasis. Expert Rev Respir Med 2014; 8: 249-262.
• King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med 2006;100(12):2183-9.
• Wilson CB, Jones PW, O'Leary CJ, Cole PJ, Wilson R. Validation of the St George’s Respiratory Questionnaire in Bronchiectasis. Am J Respir Crit Care Med 1997;156:536-41.
• Martínez-García MA, Soler-Cataluña JJ, Perpiñá-Tordera M, Román-Sánchez P, Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007;132:1565-72.
• Koulouris NG, Retsou S, Kosmas E, Dimakou K, Malagari K, Mantzikopoulos G, Koutsoukou A, Milic-Emili J, Jordanoglou J. Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis. Eur Respir J 2003; 21:743-8.
• O'Leary CJ, Wilson CB, Hansell DM, Cole PJ, Wilson R, Jones PW. Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respir Med 2002;96(9):686-692.
• Chang A, Bilton D. Exacerbations of cystic fibrosis: Non-cystic fibrosis bronchiectasis. Thorax 2008;63:269-76.
• King PT, Holdsworth SR, Freezer NJ, Villanueva E, Gallagher M, Holmes PW. Outcome in adult bronchiectasis. COPD 2005;2:27-34.
• De Soyza A, Brown JS, Loebinger MR. Research priorities in bronchiectasis. Thorax 2013;68:695-6.
• Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007;131(Suppl)4S-42S.
• Ong HK1, Lee AL, Hill CJ, Holland AE, Denehy L. Effects of pulmonary rehabilitation in bronchiectasis: a retrospective study. Chron Respir Dis 2011;8:21-30.
• Ashour M, Al-Kattan KM, Jain SK, Al-Majed S, Al-Kassimi F, Mobaireek A, Al-Hajjaj M, Al-Zear A. Surgery for unilateral bronchiectasis: results and prognostic factors. Tubercle Lung Dis 1996;77:168-172.
• Tsang KW, Bilton D. Clinical challenges in managing bronchiectasis. Respirology 2009; 14:637-50.
• Orenstein DM, Franklin BA, Doershuk CF, Hellerstein HK, Germann KJ, Horowitz JG, Stern RC. Exercise conditioning and cardiopulmonary fitness in cystic fibrosis: the effects of a 3 month supervised running programme. Chest 1981;80:392-8.
• Foster S, Thomas HM. Pulmonary rehabilitation in lung disease other than chronic obstructive pulmonary disease. Am Rev Respir Dis 1990;141:601-4.
• Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, Turner-Lawlor PJ, Payne N, Newcombe RG, Ionescu AA, Thomas J, Tunbridge J. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362-8.
• Golmohammadi K , Jacobs P , Sin DD . Economic evaluation of a community-based pulmonary rehabilitation program for COPD . Lung 2004;182:187-96.
• Salh W, Bilton D, Dodd M, Webb AK. Effect of exercise and physiotherapy in aiding sputum expectoration in adults with cystic fibrosis. Thorax 1989;44:1006-8.
• Cochrane GM, Webber BA , Clarke SW . Effects of sputum on pulmonary function. BMJ 1977;2:1181-3.
• Newall C, Stockley RA, Hill SL. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax 2005;60:943-8.
• Zhang P, Zhang F, Jiang S, Jiang G, Zhou X, Ding J, Gao W. Videoassisted thoracic surgery for bronchiectasis. Ann Thorac Surg 2011;91:239-43.
• Prieto D, Bernardo J, Matos MJ, Eugénio L, Antunes M. Surgery for bronchiectasis. Eur J Cardiothorac Surg 2001;20:19-24.
• Chalmers JD, McHugh BJ, Docherty C, Govan JR, Hill AT. Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in non-CF bronchiectasis. Thorax 2012;68:39-47.
• Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ, Fardon TC, De Soyza A, Hill AT. Derivation and validation of the bronchiectasis severity index: an international multicentre observational study. Am J Respir Crit Care Med 2014;189:576-85.
• Goeminne PC, Nawrot TS, Ruttens D, Seys S, Dupont LJ. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis. Respir Med 2014;108:287-96.
• Coutinho D, Fernandes P, Guerra M, Miranda J, Vouga L. Surgical treatment of bronchiectasis: a review of 20 years of experience. Rev Port Pneumol 2016;22:82-5.
• British Thoracic Society guideline for non-cystic fibrosis bronchiectasis. Thorax 2010;65:11-158.
• Etiene T, Spiliopoulos A, Megevand R. Bronchiectasis: indication and timing for surgery. Ann Chir 1993;47:729-35.
• Drain M, Elbond JS. Assessment and investigation of adults with bronchiectasis. Eur Respir Monogr 2011;52:32-43.
• Al-Kattan KM, Essa MA, Hajjar WM, Ashour MH, Saleh WN, Rafay MA. Surgical results for bronchiectasis based on hemodynamic (functional and morphologic) classification. J Thorac Cardiovasc Surg 2005;130(5):1385-90.
• Agasthian T, Deschamps C, Trastek VF, Allen MS, Pairolero PC. Surgical management of bronchiectasis. Ann Thorac Surg 1996;62:976-80.
• Fujimoto T, Hillejan L, Stamatis G. Current strategy for surgical management of bronchiectasis. Ann Thorac Surg 2001;72:1711-5.
• Tsang KW, Chan K, Ho P, Zheng L, Ooi GC, Ho JC, Lam W. Sputum elastase in steady-state bronchiectasis. Chest 2000;117(2):420-6.
• Anwar GA, Bourke SC, Afolabi G, Middleton P, Ward C, Rutherford RM. Effects of longterm low-dose azithromycin in patients with non-CF bronchiectasis. Respir Med 2008;102:1494-6.
• Guilemany JM, Alobid I, Angrill J, Ballesteros F, Bernal-Sprekelsen M, Picado C, Mullol J. The impact of bronchiectasis associated to sinonasal disease on quality of life. Respir Med 2006;100:1997-2003.
• Lötters F, van Tol B, Kwakkel G, Gosselink R. Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis. Eur Respir J 2002;20:570-6.
• Morano MT, Araújo AS, Nascimento FB, da Silva GF, Mesquita R, Pinto JS, de Moraes Filho MO, Pereira ED. Preoperative pulmonary rehabilitation versus chest physical therapy in patients undergoing lung cancer resection: a pilot randomized controlled trial. Arch Phys Med Rehabil 2013;94:53-8.
• Sheehan RE, Wells AU, Copley SJ, Desai SR, Howling SJ, Cole PJ, Wilson R, Hansell DM. A comparison of serial computed tomography and functional change in bronchiectasis. Eur Respir J 2002;20:581-7.
• O'Neill B, Bradley JM, McArdle N, MacMahon J. The current physiotherapy management of patients with bronchiectasis: a UK survey. Int J Clin Pract 2002;56:34-5.
• Eaton T, Young P, Zeng I, Kolbe J. A randomized evaluation of the acute efficacy, acceptability and tolerability of Flutter and active cycle of breathing with and without postural drainage in non-cystic fibrosis bronchiectasis. Chron Respir Dis 2007;4:23-30.
• Cecins NM1, Jenkins SC, Pengelley J, Ryan G. The active cycle of breathing techniques—to tip or not to tip? Respir Med 1999;93:660-5.
• Gallon A. Evaluation of chest percussion in the treatment of patients with copious sputum production. Respir Med 1991;85:45-51.
• McCarren B, Alison JA, Herbert RD. Manual vibration increases expiratory flow rate via increased intrapleural pressure in healthy adults: an experimental study. Aust J Physiother 2006;52:267-71.
• O’Connor C, Bridge P. Can the interrupter technique be used as an outcome measure for autogenic drainage in bronchiectatic patients? A pilot study. J Assoc Chartered Physiother Resp Care 2005;37:29-34.